Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients
NORML
MAY 26, 2020
Adverse events were mostly mild and resolved spontaneously. Chronic pain is the most commonly reported qualifying condition among medical cannabis patients enrolled in state-specific access programs. The 1mg dose showed a significant pain decrease compared to the placebo.
Let's personalize your content